Dephosphorylation of circulating human osteopontin correlates with severe valvular calcification in patients with calcific aortic valve disease

被引:33
作者
Sainger, Rachana [1 ]
Grau, Juan B. [1 ,2 ]
Poggio, Paolo [1 ,3 ]
Branchetti, Emanuela [1 ]
Bavaria, Joseph E. [1 ]
Gorman, Joseph H., III [1 ]
Gorman, Robert C. [1 ]
Ferrari, Giovanni [1 ]
机构
[1] Univ Penn, Dept Surg, Div Cardiovasc Surg, Perelman Sch Med, Philadelphia, PA USA
[2] Columbia Univ, Valley Columbia Heart & Vasc Ctr, Ridgewood, NJ USA
[3] Univ Milan, Dept Pharmacol Sci, Ctr Cardiol Monzino IRCCS, Milan, Italy
关键词
Osteopontin; CAVD; plasma purification; T-CELLS; STENOSIS; PROGRESSION; EXPRESSION; PATHOGENESIS; PREVALENCE; INSIGHTS; FAILURE; SURGERY; ANGINA;
D O I
10.3109/1354750X.2011.642407
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Context: Calcific Aortic Valve Disease (CAVD) is an active pathological process leading to biomineralization of the aortic cusps. We characterized circulating and tissue Osteopontin (OPN) as a biomarker for CAVD. Objectives: Here we investigate the post-translational modifications of circulating OPN and correlate the phosphorylation status with the ability to prevent calcification. Methods: Circulating OPN levels were estimated in CAVD patients (n = 51) and controls (n = 56). In a subgroup of 27 subjects, OPN was purified and the phosphorylation status analyzed. Results: Plasma OPN levels were significantly elevated in CAVD patients as compared to the controls and correlates with the aortic valve calcium score. Our study demonstrates that phospho-threonine levels of OPN purified from controls were higher when compared to CAVD subjects, whereas phospho-serine and phospho-tyrosine levels were comparable between the two groups. Conclusion: The dephosphorylation of circulating OPN correlates with severe valvular calcification in patients with CAVD.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 50 条
  • [21] Liraglutide Attenuates Aortic Valve Calcification in a High-Cholesterol-Diet-Induced Experimental Calcific Aortic Valve Disease Model in Apolipoprotein E-Deficient Mice
    Zhou, Yangzhao
    Yuan, Zhaoshun
    Wang, Min
    Zhang, Zhiyuan
    Tan, Changming
    Yu, Jiaolian
    Bi, Yanfeng
    Liao, Xiaobo
    Zhou, Xinmin
    Sheikh, Md Sayed Ali
    Yang, Dafeng
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (09)
  • [22] Osteopontin Controls Endothelial Cell Migration In Vitro and in Excised Human Valvular Tissue from Patients with Calcific Aortic Stenosis and Controls
    Poggio, Paolo
    Grau, Juan B.
    Field, Benjamin C.
    Sainger, Rachana
    Seefried, William F.
    Rizzolio, Flavio
    Ferrari, Giovanni
    JOURNAL OF CELLULAR PHYSIOLOGY, 2011, 226 (08) : 2139 - 2149
  • [23] Comparison of Transesophageal Echocardiographic Analysis and Circulating Biomarker Expression Profile in Calcific Aortic Valve Disease
    Sainger, Rachana
    Grau, Juan B.
    Branchetti, Emanuela
    Poggio, Paolo
    Lai, Eric
    Koka, Erblina
    Vernick, William J.
    Gorman, Robert C.
    Bavaria, Joseph E.
    Ferrari, Giovanni
    JOURNAL OF HEART VALVE DISEASE, 2013, 22 (02) : 156 - 165
  • [24] Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease
    Sikura, Katalin Eva
    Potor, Laszlo
    Szerafin, Tamas
    Oros, Melinda
    Nagy, Peter
    Mehes, Gabor
    Hendrik, Zoltan
    Zarjou, Abolfazl
    Agarwal, Anupam
    Posta, Nike
    Torregrossa, Roberta
    Whiteman, Matthew
    Furtos, Ibolya
    Balla, Gyorgy
    Balla, Jozsef
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (04) : 793 - 809
  • [25] IL-17A induces valvular endothelial inflammation and aggravates calcific aortic valve disease
    Yang, Zhao
    Zhang, Jichao
    Zhu, Yuexin
    Zhang, Congcong
    Li, Guang
    Liu, Shuo
    Du, Jie
    Han, Yingchun
    You, Bin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 672 : 145 - 153
  • [26] Transforming growth factor-b1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model
    Jenke, Alexander
    Kistner, Julia
    Saradar, Sarah
    Chekhoeva, Agunda
    Yazdanyar, Mariam
    Bergmann, Ann Kathrin
    Roetepohl, Melanie Vera
    Lichtenberg, Artur
    Akhyari, Payam
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2020, 319 (05): : H1123 - H1141
  • [27] Semicarbazide-Sensitive Amine Oxidase Increases in Calcific Aortic Valve Stenosis and Contributes to Valvular Interstitial Cell Calcification
    Mercier, Nathalie
    Pawelzik, Sven-Christian
    Pirault, John
    Carracedo, Miguel
    Persson, Oscar
    Wollensack, Bastien
    Franco-Cereceda, Anders
    Back, Magnus
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [28] Calcific aortic valve disease and cardiometabolic triggers: an explanation behind progression of aortic valvular disease and failure of medical therapy interventions
    Prabhakar, Akruti Patel
    Lopez-Candales, Angel
    POSTGRADUATE MEDICINE, 2024, 136 (08) : 810 - 818
  • [29] Noncanonical Wnts at the Cusp of Fibrocalcific Signaling Processes in Human Calcific Aortic Valve Disease
    Giachelli, Cecilia M.
    Speer, Mei Y.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (03) : 387 - 388
  • [30] MicroRNA-34c Inhibits Osteogenic Differentiation and Valvular Interstitial Cell Calcification via STC1-Mediated JNK Pathway in Calcific Aortic Valve Disease
    Yang, Lieming
    Zhu, Xinyuan
    Ni, Yingying
    Wu, Dawei
    Tian, Yikui
    Chen, Zhi
    Li, Mingbiao
    Zhang, Hao
    Liang, Degang
    FRONTIERS IN PHYSIOLOGY, 2020, 11